{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:08:24Z","timestamp":1780420104573,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"DOI":"10.7759\/cureus.110127","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:19:38Z","timestamp":1780417178000},"source":"Crossref","is-referenced-by-count":0,"title":["Google Trends Analysis of Interest in Pediatric Myopia-Control Spectacle Lenses Following FDA Authorization of Essilor Stellest"],"prefix":"10.7759","author":[{"given":"Arbaaz S","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor C","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S","family":"Kueny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden BA","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et al.. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016, 123:1036-42. 10.1016\/j.ophtha.2016.01.006","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.10.040","article-title":"Reducing the global burden of myopia by delaying the onset of myopia and reducing myopic progression in children: the Academy's Task Force on Myopia","volume":"128","author":"Modjtahedi BS","year":"2021","unstructured":"Modjtahedi BS, Abbott RL, Fong DS, Lum F, Tan D. Reducing the global burden of myopia by delaying the onset of myopia and reducing myopic progression in children: the Academy's Task Force on Myopia. Ophthalmology. 2021, 128:816-26. 10.1016\/j.ophtha.2020.10.040","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain P","year":"2019","unstructured":"Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019, 96:556-67. 10.1097\/OPX.0000000000001410","journal-title":"Optom Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004916.pub4","article-title":"Interventions to slow progression of myopia in children","volume":"1","author":"Walline JJ","year":"2020","unstructured":"Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2020, 1:CD004916. 10.1002\/14651858.CD004916.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","unstructured":"U.S. Food and Drug Administration. FDA authorizes marketing of first eyeglass lenses to slow progression of pediatric myopia. (2025). Accessed. October 22, 2025: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-p...."},{"key":"ref6","unstructured":"EssilorLuxottica. Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States. (2025). Accessed. October 22, 2025: https:\/\/www.essilorluxottica.com\/en\/newsroom\/press-releases\/essilor-stellest-fda\/."},{"key":"ref7","unstructured":"FDA denies Sydnexis approval for pediatric myopia treatment. (2025). https.\/\/www.empr.com\/news\/fda-denies-syndexis-approval-for-pediatric-myopia-treatment\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial","volume":"141","author":"Zadnik K","year":"2023","unstructured":"Zadnik K, Schulman E, Flitcroft I, et al.. Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial. JAMA Ophthalmol. 2023, 141:990-9. 10.1001\/jamaophthalmol.2023.2097","journal-title":"JAMA Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293595","article-title":"Exploring the knowledge, attitudes, and practice towards child eye health: a qualitative analysis of parent experience focus groups","volume":"18","author":"Sherief ST","year":"2023","unstructured":"Sherief ST, Tesfaye S, Eshetu Z, Ali A, Dimaras H. Exploring the knowledge, attitudes, and practice towards child eye health: a qualitative analysis of parent experience focus groups. PLoS One. 2023, 18:e0293595. 10.1371\/journal.pone.0293595","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2196\/19985","article-title":"Online health information seeking by parents for their children: systematic review and agenda for further research","volume":"22","author":"Kubb C","year":"2020","unstructured":"Kubb C, Foran HM. Online health information seeking by parents for their children: systematic review and agenda for further research. J Med Internet Res. 2020, 22:e19985. 10.2196\/19985","journal-title":"J Med Internet Res"},{"key":"ref11","unstructured":"Google News Initiative. Google Trends. Understanding the data. (2024). Accessed: October 22, 2025: https:\/\/newsinitiative.withgoogle.com\/resources\/trainings\/google-trends-understanding-the-data\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007, 4:e296. 10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw098","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal JL","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017, 46:348-55. 10.1093\/ije\/dyw098","journal-title":"Int J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2750","article-title":"Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis","volume":"350","author":"Kontopantelis E","year":"2015","unstructured":"Kontopantelis E, Doran T, Springate DA, Buchan I, Reeves D. Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis. BMJ. 2015, 350:h2750. 10.1136\/bmj.h2750","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S460423","article-title":"Can Google help your nearsightedness? A Google Trend analysis of public interest in myopic progression","volume":"18","author":"Panneerselvam S","year":"2024","unstructured":"Panneerselvam S, Diklich N, Tijerina J, Falcone MM, Cavuoto KM. Can Google help your nearsightedness? A Google Trend analysis of public interest in myopic progression. Clin Ophthalmol. 2024, 18:1771-7. 10.2147\/OPTH.S460423","journal-title":"Clin Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac171","article-title":"Harnessing Google Health Trends data for epidemiologic research","volume":"192","author":"Neumann K","year":"2023","unstructured":"Neumann K, Mason SM, Farkas K, Santaularia NJ, Ahern J, Riddell CA. Harnessing Google Health Trends data for epidemiologic research. Am J Epidemiol. 2023, 192:430-7. 10.1093\/aje\/kwac171","journal-title":"Am J Epidemiol"},{"key":"ref17","unstructured":"Contemporary Pediatrics. FDA authorizes Essilor Stellest eyeglass lenses to slow myopia progression in children. (2025). Accessed. October 22, 2025: https:\/\/www.contemporarypediatrics.com\/view\/fda-authorizes-essilor-stellest-eyeglass-lenses-to-slow-myopia-progressio...."},{"key":"ref18","unstructured":"From clinical results to practice integration\u2014Essilor\u00ae Stellest\u00ae lenses webinars for optometrists and opticians. (2025). Accessed. October 22, 2025: https:\/\/independentstrong.reviewob.com\/index.php\/2025\/10\/17\/from-clinical-results-to-practice-integration-upcoming-es...."},{"key":"ref19","unstructured":"Essilor Stellest lens gains FDA market authorization, will be available in U.S. in coming weeks. (2025). Accessed. November 2, 2025: https:\/\/www.visionmonday.com\/business\/article\/essilor-stellest-lens-gains-fda-market-authorization-will-be-available-...."},{"key":"ref20","unstructured":"Instagram. Essilor. (2025). Accessed. October 22, 2025: https:\/\/www.instagram.com\/essilor\/."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/opo.13190","article-title":"Parental awareness of the implications of myopia and strategies to control its progression: a survey-based study","volume":"43","author":"Ortiz-Peregrina S","year":"2023","unstructured":"Ortiz-Peregrina S, Solano-Molina S, Martino F, Castro-Torres JJ, Jim\u00e9nez JR. Parental awareness of the implications of myopia and strategies to control its progression: a survey-based study. Ophthalmic Physiol Opt. 2023, 43:1145-59. 10.1111\/opo.13190","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491963-google-trends-analysis-of-interest-in-pediatric-myopia-control-spectacle-lenses-following-fda-authorization-of-essilor-stellest","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:19:41Z","timestamp":1780417181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491963-google-trends-analysis-of-interest-in-pediatric-myopia-control-spectacle-lenses-following-fda-authorization-of-essilor-stellest"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.110127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}